The Effect of Human Lyophilized Growth Factors Versus Platelet-Rich Plasma Injection on Hair Transplantation Outcome in the Crown Area of the Scalp in Men with Androgenetic Alopecia

May 2024 in “ Archives of dermatological research ”

Ahmed R. Elshahid, Amr Mohamed Mostafa, Ahmed Waheed Kheder Fnoon, Mohamed A. Abdelshakour

human lyophilized growth factors platelet-rich plasma hair transplantation crown area androgenetic alopecia hair density hair thickness LGFs PRP

Studysummary LGFs slightly improve hair transplant results more than PRP. Our plain-language summary of this paper — not a Tressless recommendation.

The study compared the effects of human lyophilized growth factors (LGFs) and platelet-rich plasma (PRP) injections on hair transplantation outcomes in the crown area of men with androgenetic alopecia. The authors found that both treatments improved hair density and thickness, but LGFs showed a slightly higher efficacy compared to PRP. The study did not generate or analyze any datasets, and all participants provided informed consent. The research was conducted without any funding or conflicts of interest.

View this study on researchsquare.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy

research Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy

65 citations , April 2020 in “International Journal of Molecular Sciences”

This review indicates that most studies reported positive effects of platelet-rich plasma injections for treating androgenic alopecia, with no major side effects, suggesting it may be a safe alternative to Minoxidil and Finasteride.

research Potential Targets in the Discovery of New Hair Growth Promoters for Androgenic Alopecia

59 citations , May 2014 in “Expert Opinion on Therapeutic Targets”

This review discusses current therapeutic targets and treatments for androgenic alopecia but reports no clinical results; the authors highlight the challenge of developing multi-target drugs for effective treatment.